Skip to content


Our Team

Ruoxi Hu, PhD

Rosy joined Mass General Brigham Innovation Fund in 2017. Previously, Rosy was a Consultant at Clarion Healthcare, a boutique life sciences consulting firm. At Clarion, she worked with a range of clients from global pharmaceutical companies to emerging biotechs on commercial strategy for preclinical/clinical stage therapeutics in oncology, immunology, CNS, and rare diseases. She received her PhD in Biological Sciences in Public Health from Harvard University, studying role of microRNAs in asthma pathogenesis. She received her BSc Honors in Life Sciences from Queen’s University in Canada.